Jocelyn Kaiser. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » AnimalsAntineoplastic Agents/pharmacologyAntineoplastic Agents/therapeutic useAntineoplastic Combined Chemotherapy Protocols/therapeutic useColonic Neoplasms/drug therapyGenes, rasHumansLung Neoplasms/drug therapyLung Neoplasms/immunologyMiceMutationPiperazines/pharmacologyPiperazines/therapeutic useProgrammed Cell Death 1 Receptor/antagonists & inhibitorsProto-Oncogene Proteins p21(ras)/antagonists & inhibitorsProto-Oncogene Proteins p21(ras)/geneticsPyridines/pharmacologyPyridines/therapeutic usePyrimidines/pharmacologyPyrimidines/therapeutic use
Substances： See more » Antineoplastic AgentsKRAS protein, humanPDCD1 protein, humanPiperazinesProgrammed Cell Death 1 ReceptorPyridinesPyrimidinessotorasibProto-Oncogene Proteins p21(ras)
Year: 2019 PMID： 31672875 DOI： 10.1126/science.366.6465.561
Source DB: PubMed Journal: Science ISSN： 0036-8075 Impact factor: 47.728